M Cosentino
Overview
Explore the profile of M Cosentino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
608
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vives A, Munoz C, Alonso-Tarres C, Cosentino M
Actas Urol Esp (Engl Ed)
. 2024 May;
48(8):618-619.
PMID: 38735435
No abstract available.
2.
De Santis R, Cagnoli G, Rinaldi B, Consonni D, Conti B, Eoli M, et al.
Fam Cancer
. 2024 Jan;
23(1):35-40.
PMID: 38270845
Neurofibromatosis type 1 (NF1) is an autosomal dominant condition caused by neurofibromin haploinsufficiency due to pathogenic variants in the NF1 gene. Tumor predisposition has long been associated with NF1, and...
3.
Vives A, Cosentino M, Palou J
Actas Urol Esp (Engl Ed)
. 2019 Dec;
44(2):86-93.
PMID: 31874781
Human papilloma virus (HPV) infection is the most common sexually transmitted infection worldwide. There is a high detection rate in sexually active young people but the risk, in males, persists...
4.
Ledda A, Belcaro G, Dugall M, Luzzi R, Hosoi M, Feragalli B, et al.
Eur Rev Med Pharmacol Sci
. 2017 Oct;
21(18):4196-4202.
PMID: 29028078
Objective: Oncological treatments are associated with toxicities that may decrease compliance to treatment in most genitourinary cancer patients. Supplementation with pharmaceutical-standardized supplement may be a supplementary method to control the...
5.
Giufre M, Ricchizzi E, Accogli M, Barbanti F, Monaco M, Pimentel de Araujo F, et al.
Clin Microbiol Infect
. 2017 Apr;
23(12):961-967.
PMID: 28412380
Objectives: To determine prevalence and risk factors for colonization by multidrug-resistant organisms (MDROs) in long-term care facility (LTCF) residents in Italy. Genotypes of MDRO isolates were investigated. Methods: A point-prevalence...
6.
Ferrari M, Comi C, Marino F, Magistrelli L, De Marchi F, Cantello R, et al.
Eur J Clin Pharmacol
. 2016 Aug;
72(11):1335-1341.
PMID: 27497990
Background: Visual hallucinations (VHs) are frequent non-motor complication of Parkinson's disease (PD), associated to a negative prognosis. Previous studies showed an association between dopamine receptor (DR) gene (DR) variants and...
7.
Cosentino V, Fratter A, Cosentino M
Eur Rev Med Pharmacol Sci
. 2016 Apr;
20(7):1390-8.
PMID: 27097964
Objective: In this Open Controlled Trial we administered an innovative formulation of food supplement with curcumin (Killox®) to test its efficacy, safety and compatibility with other drugs, in the therapy...
8.
Cosentino M, Kanashiro A, Vives A, Sanchez J, Peraza M, Moreno D, et al.
Int J Impot Res
. 2016 Apr;
28(3):106-9.
PMID: 27030055
The objective of the study was to report our results using a porcine small intestinal submucosa graft (Surgisis ES, Cook Medical) for tunica albuginea substitution after plaque incision. We retrospectively...
9.
Loraschi A, Bellantonio P, Bortolon F, Capra R, Cavalla P, Costantino G, et al.
Neurol Sci
. 2016 Feb;
37(4):613-22.
PMID: 26895323
Though recent progress in multiple sclerosis (MS) treatment is remarkable, numerous unmet needs remain to be addressed often inducing patients to look for complementary and alternative medicines (CAM), especially herbal...
10.
Peli M, Capalbo E, Lovisatti M, Cosentino M, Berti E, Mattai Dal Moro R, et al.
J Ultrasound
. 2013 Feb;
15(2):102-7.
PMID: 23396868
Introduction: Given the high prevalence of thyroid nodules in the general population it is essential to develop a method for identifying those nodules which require fine-needle aspiration biopsy (FNAB) due...